A detailed history of Assetmark, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Assetmark, Inc holds 23,408 shares of EW stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,408
Previous 21,275 10.03%
Holding current value
$1.53 Million
Previous $2.03 Million 6.35%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $179,811 - $201,163
2,133 Added 10.03%
23,408 $2.16 Million
Q1 2024

May 06, 2024

SELL
$72.54 - $95.56 $867,215 - $1.14 Million
-11,955 Reduced 35.98%
21,275 $2.03 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $2.5 Million - $3.15 Million
-40,549 Reduced 54.96%
33,230 $2.53 Million
Q3 2023

Oct 27, 2023

BUY
$69.28 - $93.38 $717,810 - $967,510
10,361 Added 16.34%
73,779 $5.11 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $427,483 - $495,326
5,251 Added 9.03%
63,418 $5.98 Million
Q1 2023

May 05, 2023

SELL
$74.26 - $84.51 $738,812 - $840,789
-9,949 Reduced 14.61%
58,167 $4.81 Million
Q4 2022

Feb 10, 2023

BUY
$68.3 - $87.44 $690,513 - $884,018
10,110 Added 17.43%
68,116 $5.08 Million
Q3 2022

Nov 01, 2022

BUY
$82.37 - $107.29 $293,896 - $382,810
3,568 Added 6.55%
58,006 $4.79 Million
Q2 2022

Aug 03, 2022

BUY
$86.5 - $128.27 $859,637 - $1.27 Million
9,938 Added 22.33%
54,438 $5.18 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $2.07 Million - $2.6 Million
20,254 Added 83.54%
44,500 $5.24 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $2.4 Million - $2.95 Million
22,548 Added 1327.92%
24,246 $3.14 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $123,800 - $147,668
1,203 Added 243.03%
1,698 $192,000
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $11,318 - $14,142
135 Added 37.5%
495 $51,000
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $6,609 - $7,616
-84 Reduced 18.92%
360 $30,000
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $4,301 - $5,473
-60 Reduced 11.9%
444 $41,000
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $176,978 - $230,316
-2,634 Reduced 83.94%
504 $40,000
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $173,655 - $232,235
3,018 Added 2515.0%
3,138 $217,000
Q1 2020

May 12, 2020

SELL
$52.41 - $81.0 $157 - $243
-3 Reduced 2.44%
120 $23,000
Q4 2019

Feb 11, 2020

SELL
$71.7 - $82.09 $3,728 - $4,268
-52 Reduced 29.71%
123 $29,000
Q3 2019

Nov 13, 2019

SELL
$61.55 - $75.43 $615 - $754
-10 Reduced 5.41%
175 $38,000
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $390 - $450
-7 Reduced 3.65%
185 $34,000
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $5,076 - $6,789
-106 Reduced 35.57%
192 $37,000
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $324 - $398
7 Added 2.41%
298 $46,000
Q1 2018

May 16, 2018

SELL
$37.19 - $47.45 $11,119 - $14,187
-299 Reduced 50.68%
291 $41,000
Q4 2017

Feb 13, 2018

SELL
$33.79 - $39.39 $1,757 - $2,048
-52 Reduced 8.1%
590 $67,000
Q3 2017

Nov 08, 2017

BUY
$36.29 - $38.83 $3,556 - $3,805
98 Added 18.01%
642 $70,000
Q2 2017

Aug 15, 2017

SELL
N/A
-14 Reduced 2.51%
544 $64,000
Q1 2017

Sep 15, 2017

BUY
N/A
337 Added 152.49%
558 $52,000
Q4 2016

Sep 15, 2017

BUY
N/A
23 Added 11.62%
221 $21,000
Q3 2016

Sep 15, 2017

BUY
N/A
14 Added 7.61%
198 $24,000
Q1 2016

Sep 15, 2017

BUY
N/A
56 Added 43.75%
184 $16,000
Q4 2015

Sep 15, 2017

BUY
N/A
128
128 $10,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.